San Diego Business Journal

Failure of Key Gene Therapy Trial Leaves Vical in a Difficult Position

BIOTECH: After 20-Year Effort, Firm Must Switch Gears By Meghana Keshavan Monday, September 2, 2013

San Diego pharmaceutical company Vical Inc...


Page 1 of 2.

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129